We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Endoscope Targets Colon Tumors

By MedImaging International staff writers
Posted on 18 May 2017
Print article
Image: The new endoscope will enable faster, more accurate colorectal cancer diagnosis (Photo courtesy of the Tyndall National Institute).
Image: The new endoscope will enable faster, more accurate colorectal cancer diagnosis (Photo courtesy of the Tyndall National Institute).
An innovative endoscope will use breakthrough photonics technology to enable rapid, accurate diagnosis of bowel polyps and early colon cancer.

The PhotonICs endoscope for improved in-vivo COLOn Cancer diagnosis and clinical decision support (PICCOLO), under development at Tyndall National Institute, Tecnalia, and other institutions, is a multimodal photonic endoscope with high sensitivity that will use both optical coherence tomography (OCT) and multi-photon tomography (MPT), combined with fluorescence technology, in order to facilitate real time computer aided diagnosis (CAD) of colon cancer via high-resolution structural and functional imaging.

The PICCOLO will be able to detail changes occurring at the cellular level, comparable to those obtained using traditional histological techniques. According to the researchers, the endoscope will not only provide a new approach in colon cancer detection, but its image-based diagnosis methods could be applied to diseases in other organs of the body. The PICCOLO multidisciplinary development team, which includes clinicians, photonics components and technology providers, endoscope providers, and medical software developers hope to have refined the first prototype by the end of 2018, and target clinical trials to begin around 2020.

“When multiple polyps are detected in a patient, the current gold standard procedure is to remove all of them, followed by microscopic tissue analysis,” said computer vision researcher Artzai Picon, PhD, of Tecnalia. “Removal of hyperplastic polyps, which carry no malignant potential, and the subsequent costly histolopathological analysis might be avoided through the use of the PICCOLO endoscope probe, which could allow image-based diagnosis without the need for tissue biopsies.”

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Under Table Shield
3 Section Double Pivot Under Table Shield
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
New
Brachytherapy Planning System
Oncentra Brachy

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.